Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from ...

J.P. Morgan, Morgan Stanley, TD Cowen and UBS Investment Bank are acting as lead book-running managers for the offering.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2026 financial and ...

OCT-980 is designed to stabilize misfolded rhodopsin and restore proper cellular trafficking. By directly targeting the ...

Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment ...

Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of ...

The 2026 honorees include innovative companies whose treatments have significantly improved rare disease patient outcomes, ...

Compact system offers research laboratories a time-saving and cost-efficient way to automate work still done by hand ...

Metastasis—the spread of cancer from a primary tumor to other parts of the body—causes most cancer-related deaths. But how ...

COPENHAGEN, Denmark; September 24, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to ...

Elephas Biosciences Corporation, developer of a functional precision medicine platform for oncology therapy response ...

Led by Relevance Ventures, the funding will support the completion of Aqua Medical's ongoing U.S. RESTORE-1 pilot study ...